HealthTree Foundation Introduces AI Clinical Trial Finder for Myeloma Patients

HealthTree Foundation has launched an AI-powered Personalized Clinical Trial Finder, designed to match multiple myeloma patients with eligible clinical trials based on their medical records, announced in a press release. This new feature is integrated into the HealthTree Cure Hub Registry and aims to streamline the process of finding suitable clinical trials by analyzing patients' unique medical data against trial eligibility criteria.

The tool addresses the complexity and time-consuming nature of manually searching for clinical trials by providing a curated list of trials for which a patient qualifies. This innovation is particularly significant during Myeloma Awareness Month, as it enhances patients' access to cutting-edge therapies currently in development.

HealthTree's Founder and CEO, Jenny Ahlstrom, emphasized the personalized nature of the tool, which uses tens of thousands of data points to ensure accurate trial matches. The foundation's CTO, Juan Pablo Capdevila, highlighted the role of AI in enabling real-time data analysis for instant trial matching, thus saving time for both patients and clinicians while accelerating study enrollment.